Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more
Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more |
https://doi.org/10.18632/oncotarget.23005
Haris Zahoor,
Brian I. Rini,
and Moshe C. Ornstein
|
14036-14037 |
Serum microRNAs – potent biomarkers for radiation biodosimetry
Serum microRNAs – potent biomarkers for radiation biodosimetry |
https://doi.org/10.18632/oncotarget.24381
Bartłomiej Tomasik,
Wojciech Fendler,
and Dipanjan Chowdhury
|
14038-14039 |
Breast cancer cells exploit mitophagy to exert therapy resistance
Breast cancer cells exploit mitophagy to exert therapy resistance |
https://doi.org/10.18632/oncotarget.24533
Liana Hardy,
Michele Frison,
and Michelangelo Campanella
|
14040-14041 |
Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model
Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model |
https://doi.org/10.18632/oncotarget.24449
Yuko Iwata,
Yoshimi Katayama,
Yasushi Okuno,
and Shigeo Wakabayashi
|
14042-14057 |
Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment
Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment |
https://doi.org/10.18632/oncotarget.24500
Kenji Imai,
Koji Takai,
Toshihide Maeda,
Satoshi Watanabe,
Tatsunori Hanai,
Atsushi Suetsugu,
Makoto Shiraki,
and Masahito Shimizu
|
14058-14067 |
Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma
Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.23774
Jie Liang,
Guodong Li,
Jun Xu,
Tong Wang,
Yanyan Jia,
Qinghua Zhai,
Lihua Qiao,
Miao Chen,
Yajing Guo,
and Shujun Zhang
|
14068-14076 |
Genetic variation of CXCR4 and risk of coronary artery disease: epidemiological study and functional validation of CRISPR/Cas9 system
Genetic variation of CXCR4 and risk of coronary artery disease: epidemiological study and functional validation of CRISPR/Cas9 system |
https://doi.org/10.18632/oncotarget.23491
Guo Runmin,
Jiang Jiamei,
Jing Zhiliang,
Chen Yonghua,
Shi Zhizhou,
Tao GuiZhou,
and Liu Shuguang
|
14077-14083 |
Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer
Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer |
https://doi.org/10.18632/oncotarget.23505
Yunxia Ma,
Yuan Chen,
Yong Li,
Katja Grün,
Alexander Berndt,
Zhongwei Zhou,
and Iver Petersen
|
14084-14098 |
Orthotopic hepatic cancer: radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy
Orthotopic hepatic cancer: radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy |
https://doi.org/10.18632/oncotarget.23586
Fu Xiong,
Feng Zhang,
Yin Jin,
Qiaoyou Weng,
Jingjing Song,
Guofeng Zhou,
David Shin,
Chuansheng Zheng,
and Xiaoming Yang
|
14099-14108 |
Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma
Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma |
https://doi.org/10.18632/oncotarget.23881
Yuanyuan Zhang,
Haixing Mai,
Gang Guo,
Guofang Bi,
Guangtao Hao,
Yuanyuan Li,
Xiaofang Wang,
Longmei Cheng,
Jing Wang,
Ruihua Dong,
Zeyuan Liu,
Lijun Chen,
and Hengyan Qu
|
14109-14123 |
AP-1 confers resistance to anti-cancer therapy by activating XIAP
AP-1 confers resistance to anti-cancer therapy by activating XIAP |
https://doi.org/10.18632/oncotarget.23897
Yuan Wang,
Guo-Hui Wan,
Ying-Min Wu,
Hong-Sheng Wang,
Hai-Fang Wang,
Ge Zhang,
Lin-Lin Lu,
Zi-Qian Li,
Ka-Ying Chan,
Yan Zhou,
Shao-Hui Cai,
Yi- Fei Qi,
and Jun Du
|
14124-14137 |
Perspectives of patients and physicians about neuroendocrine tumors. A qualitative study
Perspectives of patients and physicians about neuroendocrine tumors. A qualitative study |
https://doi.org/10.18632/oncotarget.24347
Jordan Sibeoni,
Wafaa Khannoussi,
Emilie Manolios,
Vinciane Rebours,
Anne Revah-Levy,
and Philippe Ruszniewski
|
14138-14147 |
Synergistic effects of inhibiting the MNK-eIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDA-MB-231 cells
Synergistic effects of inhibiting the MNK-eIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDA-MB-231 cells |
https://doi.org/10.18632/oncotarget.24354
Ella Lineham,
Graham J. Tizzard,
Simon J. Coles,
John Spencer,
and Simon J. Morley
|
14148-14159 |
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report |
https://doi.org/10.18632/oncotarget.24389
Giovani M. Favero,
Jessica L. Paz,
Andréia H. Otake,
Durvanei A. Maria,
Elia G. Caldini,
Raphael S.S. de Medeiros,
Debora F. Deus,
Roger Chammas,
Raul C. Maranhão,
and Sergio P. Bydlowski
|
14160-14174 |
RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer
RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer |
https://doi.org/10.18632/oncotarget.24419
Madhura Kulkarni,
Tuan Zea Tan,
Nurfarhanah Bte Syed Sulaiman,
John M. Lamar,
Prashali Bansal,
Jianzhou Cui,
Yiting Qiao,
and Yoshiaki Ito
|
14175-14192 |
Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer
Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer |
https://doi.org/10.18632/oncotarget.24447
Shigeo Yamaguchi,
Shin Takahashi,
Kaoru Mogushi,
Yuki Izumi,
Yumi Nozaki,
Tadashi Nomizu,
Yoichiro Kakugawa,
Takanori Ishida,
Noriaki Ohuchi,
Chikashi Ishioka,
and Shunsuke Kato
|
14193-14206 |
High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy
High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy |
https://doi.org/10.18632/oncotarget.24453
Tomoaki Terakawa,
Eriko Katsuta,
Li Yan,
Nitesh Turaga,
Kerry-Ann McDonald,
Masato Fujisawa,
Khurshid A. Guru,
and Kazuaki Takabe
|
14207-14218 |
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients |
https://doi.org/10.18632/oncotarget.24478
Mario Tiribelli,
Massimiliano Bonifacio,
Gianni Binotto,
Alessandra Iurlo,
Francesca Cibien,
Elena Maino,
Anna Guella,
Gianluca Festini,
Claudia Minotto,
Ercole De Biasi,
Federico De Marchi,
Luigi Scaffidi,
Luca Frison,
Cristina Bucelli,
Marta Medeot,
Elisabetta Calistri,
Rosaria Sancetta,
Manuela Stulle,
Nicola Orofino,
Mauro Krampera,
Filippo Gherlinzoni,
Gianpietro Semenzato,
Giovanni Pizzolo,
Achille Ambrosetti,
and Renato Fanin
|
14219-14227 |
Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway
Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway |
https://doi.org/10.18632/oncotarget.24479
Anna Makowska,
Lora Wahab,
Till Braunschweig,
Nikiforos-Ioannis Kapetanakis,
Christian Vokuhl,
Bernd Denecke,
Lian Shen,
Pierre Busson,
and Udo Kontny
|
14228-14250 |
Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer
Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer |
https://doi.org/10.18632/oncotarget.24484
Dustin B. Manders,
Hari Annavarapu Kishore,
Adi F. Gazdar,
Patrick W. Keller,
Jun Tsunezumi,
Hiromi Yanagisawa,
Jayanthi Lea,
and Ruth Ann Word
|
14251-14267 |
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.24361
Daniel Richard Gomez,
Lauren Averett Byers,
Monique Nilsson,
Lixia Diao,
Jing Wang,
Lerong Li,
Pan Tong,
Mia Hofstad,
Babita Saigal,
Ignacio Wistuba,
Neda Kalhor,
Stephen Swisher,
Youhong Fan,
Waun Ki Hong,
Milind Suraokar,
Carmen Behrens,
Cesar Moran,
and John Victor Heymach
|
14268-14284 |
Comparative study of interhemispheric functional connectivity in left eye monocular blindness versus right eye monocular blindness: a resting-state functional MRI study
Comparative study of interhemispheric functional connectivity in left eye monocular blindness versus right eye monocular blindness: a resting-state functional MRI study |
https://doi.org/10.18632/oncotarget.24487
Yi Shao,
Jing Bao,
Xin Huang,
Fu-Qing Zhou,
Lei Ye,
You-Lan Min,
Lin Yang,
Zubin Sethi,
Qing Yuan,
and Qiong Zhou
|
14285-14295 |
Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy
Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy |
https://doi.org/10.18632/oncotarget.24507
Hironori Fukuda,
Toshio Takagi,
Tsunenori Kondo,
Satoru Shimizu,
and Kazunari Tanabe
|
14296-14305 |
TP53 mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [18F] fluorodeoxyglucose (18F-FDG PET)
TP53 mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [18F] fluorodeoxyglucose (18F-FDG PET) |
https://doi.org/10.18632/oncotarget.24508
Geraldine H. Chang,
Razelle Kurzrock,
Lisa Tran,
Maria Schwaederle,
and Carl K. Hoh
|
14306-14310 |
Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog
Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog |
https://doi.org/10.18632/oncotarget.24510
Bhairavi Tolani,
Ngoc T. Hoang,
Luis A. Acevedo,
Etienne Giroux Leprieur,
Hui Li,
Biao He,
and David M. Jablons
|
14311-14323 |
Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration
Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration |
https://doi.org/10.18632/oncotarget.24511
Haijun Zhang,
Jing Yang,
Matthew S. Walters,
Michelle R. Staudt,
Yael Strulovici-Barel,
Jacqueline Salit,
Jason G. Mezey,
Philip L. Leopold,
and Ronald G. Crystal
|
14324-14337 |
Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma
Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma |
https://doi.org/10.18632/oncotarget.24512
Stefan Nagel,
Claudia Pommerenke,
Corinna Meyer,
Maren Kaufmann,
Roderick A.F. MacLeod,
and Hans G. Drexler
|
14338-14353 |
Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer |
https://doi.org/10.18632/oncotarget.24436
Won Tae Kim,
Ye Hwan Kim,
Pildu Jeong,
Sung-Pil Seo,
Ho-Won Kang,
Yong-June Kim,
Seok Joong Yun,
Sang-Cheol Lee,
Sung-Kwon Moon,
Yung-Hyun Choi,
Geun Taek Lee,
Isaac Yi Kim,
and Wun-Jae Kim
|
14354-14365 |
Interactome analysis of transforming growth factor-β-activated kinase 1 in Helicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37
Interactome analysis of transforming growth factor-β-activated kinase 1 in Helicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37 |
https://doi.org/10.18632/oncotarget.24544
Olga Sokolova,
Thilo Kähne,
Kenneth Bryan,
and Michael Naumann
|
14366-14381 |
MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart
MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart |
https://doi.org/10.18632/oncotarget.24205
Yanru Zhao,
Mengwen Yan,
Chen Chen,
Wei Gong,
Zhongwei Yin,
Huaping Li,
Jiahui Fan,
Xin A. Zhang,
Dao Wen Wang,
and Houjuan Zuo
|
14382-14396 |
RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis
RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis |
https://doi.org/10.18632/oncotarget.24208
Qinglian Wang,
Xiaowei Yang,
Ying Xu,
Zhenwei Shen,
Hongxia Cheng,
Fajuan Cheng,
Xiang Liu,
and Rong Wang
|
14397-14412 |
The protective autophagy activated by GANT-61 in MYCN amplified neuroblastoma cells is mediated by PERK
The protective autophagy activated by GANT-61 in MYCN amplified neuroblastoma cells is mediated by PERK |
https://doi.org/10.18632/oncotarget.24214
Jing Wang,
Siqi Huang,
Ruicheng Tian,
Jing Chen,
Hongxiang Gao,
Chenjie Xie,
Yuhua Shan,
Zhen Zhang,
Song Gu,
and Min Xu
|
14413-14427 |
IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma
IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma |
https://doi.org/10.18632/oncotarget.24467
Yu Tanabe,
Yoshiyuki Suehara,
Shinji Kohsaka,
Takuo Hayashi,
Keisuke Akaike,
Kenta Mukaihara,
Taisei Kurihara,
Youngji Kim,
Taketo Okubo,
Midori Ishii,
Saiko Kazuno,
Kazuo Kaneko,
and Tsuyoshi Saito
|
14428-14443 |
Association between angiotensin II receptor type 1 A1166C polymorphism and chronic kidney disease
Association between angiotensin II receptor type 1 A1166C polymorphism and chronic kidney disease |
https://doi.org/10.18632/oncotarget.24469
Hsien-Feng Chang,
Po-Jen Hsiao,
Yu-Juei Hsu,
Fu-Huang Lin,
Chin Lin,
Wen Su,
Hsiang-Cheng Chen,
and Sui-Lung Su
|
14444-14455 |
Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN
Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN |
https://doi.org/10.18632/oncotarget.24470
Longjiang Shao,
Jianghua Wang,
Omer Faruk Karatas,
Shu Feng,
Yiqun Zhang,
Chad J. Creighton,
and Michael Ittmann
|
14456-14471 |
Trends in the prevalence of congenital hydrocephalus in 14 cities in Liaoning province, China from 2006 to 2015 in a population-based birth defect registry from the Liaoning Women and Children's Health Hospital
Trends in the prevalence of congenital hydrocephalus in 14 cities in Liaoning province, China from 2006 to 2015 in a population-based birth defect registry from the Liaoning Women and Children's Health Hospital |
https://doi.org/10.18632/oncotarget.24239
Yan-Hong Huang,
Qi-Jun Wu,
Yan-Ling Chen,
Cheng-Zhi Jiang,
Ting-Ting Gong,
Jing Li,
Li-Li Li,
and Chen Zhou
|
14472-14480 |
Depleting ovarian cancer stem cells with calcitriol
Depleting ovarian cancer stem cells with calcitriol |
https://doi.org/10.18632/oncotarget.24520
Amit Kumar Srivastava,
Asim Rizvi,
Tiantian Cui,
Chunhua Han,
Ananya Banerjee,
Imrana Naseem,
Yanfang Zheng,
Altaf A. Wani,
and Qi-En Wang
|
14481-14491 |
A pilot study on primary cultures of human respiratory tract epithelial cells to predict patients’ responses to H7N9 infection
A pilot study on primary cultures of human respiratory tract epithelial cells to predict patients’ responses to H7N9 infection |
https://doi.org/10.18632/oncotarget.24537
Chung-Guei Huang,
Li-Ang Lee,
Yi-Cheng Wu,
Mei-Jen Hsiao,
Jim-Tong Horng,
Rei-Lin Kuo,
Chih-Heng Huang,
Ya-Chu Lin,
Kuo-Chien Tsao,
Min-Chi Chen,
Tse-Ching Chen,
and Shin-Ru Shih
|
14492-14508 |
Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-κB activation
Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-κB activation |
https://doi.org/10.18632/oncotarget.24429
Chitra Subramanian,
Patrick T. Grogan,
Valerie P. Opipari,
Barbara N. Timmermann,
and Mark S. Cohen
|
14509-14523 |
The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models
The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models |
https://doi.org/10.18632/oncotarget.24539
Panshak P. Dakup,
Kenneth I. Porter,
Alexander A. Little,
Rajendra P. Gajula,
Hui Zhang,
Elena Skornyakov,
Michael G. Kemp,
Hans P.A. Van Dongen,
and Shobhan Gaddameedhi
|
14524-14538 |
Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells
Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells |
https://doi.org/10.18632/oncotarget.24465
Annabelle Congras,
Nina Caillet,
Nouritza Torossian,
Cathy Quelen,
Camille Daugrois,
Pierre Brousset,
Laurence Lamant,
Fabienne Meggetto,
and Coralie Hoareau-Aveilla
|
14539-14551 |
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.24545
Aidan M. Rose,
Lindsay C. Spender,
Christopher Stephen,
Alastair Mitchell,
William Rickaby,
Susan Bray,
Alan T. Evans,
Jasbani Dayal,
Karin J. Purdie,
Catherine A. Harwood,
Charlotte M Proby,
Irene M. Leigh,
Philip J. Coates,
and Gareth J. Inman
|
14552-14566 |
Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy
Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy |
https://doi.org/10.18632/oncotarget.24516
Silvina Odete Bustos,
Gustavo José da Silva Pereira,
Renata de Freitas Saito,
Cristiane Damas Gil,
Daniela Bertolli Zanatta,
Soraya Soubhi Smaili,
and Roger Chammas
|
14567-14579 |
Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis
Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis |
https://doi.org/10.18632/oncotarget.24522
Lucia Coscujuela Tarrero,
Giulio Ferrero,
Valentina Miano,
Carlo De Intinis,
Laura Ricci,
Maddalena Arigoni,
Federica Riccardo,
Laura Annaratone,
Isabella Castellano,
Raffaele A. Calogero,
Marco Beccuti,
Francesca Cordero,
and Michele De Bortoli
|
14580-14596 |
Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma
Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma |
https://doi.org/10.18632/oncotarget.24523
Emily A. Bassett,
Kamalakannan Palanichamy,
Mitchell Pearson,
Joseph P. McElroy,
Saikh Jaharul Haque,
Erica Hlavin Bell,
and Arnab Chakravarti
|
14597-14607 |
Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis
Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis |
https://doi.org/10.18632/oncotarget.21825
Han Wang,
Yang Liu,
Jianhua Zhong,
Chenglong Wu,
Yuantang Zhong,
Gang Yang,
Jinghua Zhang,
and Aifa Tang
|
14608-14618 |
The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis
The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis |
https://doi.org/10.18632/oncotarget.23657
Shiqian Han,
Yuanduo Hong,
Tingting Liu,
Na Wu,
and Zhijia Ye
|
14619-14629 |
Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment
Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment |
https://doi.org/10.18632/oncotarget.24318
Junbao Wei,
Hengzong Zhu,
and Xiaoli Liao
|
14630-14641 |
Clinicopathological and prognostic significance of Twist overexpression in NSCLC
Clinicopathological and prognostic significance of Twist overexpression in NSCLC |
https://doi.org/10.18632/oncotarget.24489
Meng Li,
Xing Zhang,
Xiaoqing Xu,
Jiubin Wu,
Kaiwen Hu,
Xiuwei Guo,
and Peitong Zhang
|
14642-14651 |
Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma
Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma |
https://doi.org/10.18632/oncotarget.24007
Bao Guan,
Yicong Du,
Xiaohong Su,
Zhenpeng Cao,
Yifan Li,
Yonghao Zhan,
Ding Peng,
Gengyan Xiong,
Dong Fang,
Yi Ding,
Shiming He,
Yanqing Gong,
Qun He,
Xuesong Li,
and Liqun Zhou
|
14652-14660 |
Type 2 diabetes mellitus-related changes in left ventricular structure and function in patients with chronic kidney disease
Type 2 diabetes mellitus-related changes in left ventricular structure and function in patients with chronic kidney disease |
https://doi.org/10.18632/oncotarget.24482
Pei-Yu Wu,
Jiun-Chi Huang,
Szu-Chia Chen,
and Ling-I Chen
|
14661-14668 |
Healthy efficacy of Nostoc commune Vaucher
Healthy efficacy of Nostoc commune Vaucher |
https://doi.org/10.18632/oncotarget.23620
Zhuoyu Li,
and Min Guo
|
14669-14679 |
Old Sonic Hedgehog, new tricks: a new paradigm in thoracic malignancies
Old Sonic Hedgehog, new tricks: a new paradigm in thoracic malignancies |
https://doi.org/10.18632/oncotarget.24411
Etienne Giroux Leprieur,
David M. Jablons,
and Biao He
|
14680-14691 |
Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization
Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization |
https://doi.org/10.18632/oncotarget.24461
Franco Cortese,
Dmitry Klokov,
Andreyan Osipov,
Jakub Stefaniak,
Alexey Moskalev,
Jane Schastnaya,
Charles Cantor,
Alexander Aliper,
Polina Mamoshina,
Igor Ushakov,
Alex Sapetsky,
Quentin Vanhaelen,
Irina Alchinova,
Mikhail Karganov,
Olga Kovalchuk,
Ruth Wilkins,
Andrey Shtemberg,
Marjan Moreels,
Sarah Baatout,
Evgeny Izumchenko,
João Pedro de Magalhães,
Artem V. Artemov,
Sylvain V. Costes,
Afshin Beheshti,
Xiao Wen Mao,
Michael J. Pecaut,
Dmitry Kaminskiy,
Ivan V. Ozerov,
Morten Scheibye-Knudsen,
and Alex Zhavoronkov
|
14692-14722 |
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification |
https://doi.org/10.18632/oncotarget.24515
Kentaro Inamura
|
14723-14737 |
Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status
Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status |
https://doi.org/10.18632/oncotarget.24553
Aman Chauhan,
Susanne M. Arnold,
Jill Kolesar,
Hala Elnakat Thomas,
Mark Evers,
and Lowell Anthony
|
14738-14740 |